Latest filing published 24 Apr 2025 for 루트락.
엘앤케이바이오: trading record in brief
엘앤케이바이오 is a declared insider of 루트락, with filings sourced from DART (FSS). In total, 6 filings cover trades dated from 12 September 2023 to 24 April 2025.
Market trades split into 4 purchases and 1 sale. The amount is not disclosed for 5 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2025 alone, the filings show no purchases and 1 sale.
None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 24 April 2025, reports an open-market sale in 루트락. The clock since the last published purchase (26 December 2024) now reads 684 days. Between a trade and the moment it shows up on DART (FSS), the median delay is 35 days. That lag is the time during which only the insider knows about the trade. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 엘앤케이바이오
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 105,325 sharesKRXDART:20241226000368Canonical exit: 26 Mar 2025 (T+90)
- ShareKRXDART:20240711000052Canonical exit: 9 Oct 2024 (T+90)
- 1,135,796 sharesKRXDART:20240626000404Canonical exit: 24 Sept 2024 (T+90)
- ShareKRXDART:20240626000396Canonical exit: 24 Sept 2024 (T+90)
6 of 6 declarations